Tirzepatide
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 160
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide | Obesity or overweight | n/r | 90 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 90 | n/r | n/r |